--2024/Q4-- / 7.985M--
--2024/Q3-- / 7.892M--
Aug 8, 20242024/Q26.957M / 19.162M--
May 9, 20242024/Q128.935M / 9.065M--
Feb 22, 20242023/Q4-1.917M / 11.359M--
US Stock MarketDetailed Quotes
NTLA Intellia Therapeutics
- 21.460
- -0.920-4.11%
Close Aug 9 16:00 ET
- 21.500
- +0.040+0.19%
Post 20:02 ET
2.18BMarket Cap-3916P/E (TTM)
22.610High21.130Low1.45MVolume22.400Open22.380Pre Close31.17MTurnover1.45%Turnover RatioLossP/E (Static)101.58MShares39.14052wk High2.24P/B2.15BFloat Cap19.37052wk Low--Dividend TTM100.33MShs Float202.730Historical High--Div YieldTTM6.61%Amplitude9.180Historical Low21.504Avg Price1Lot Size
Intellia Therapeutics Key Stats
Intellia Therapeutics Earnings Date
Currency: USD
Period
Q2 FY2024 Earnings
Aug 8, 2024
Revenue(YoY)
6.96M
-48.82%EPS(YoY)
-1.52
-8.57%Analyst Rating
Aug 11, 2024
Intellia Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 13 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Intellia Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
